Article
A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.
Arteriosclerosis, thrombosis, and vascular biology - 1 Mar 2011
Johnson Jason L, Devel Laurent, Czarny Bertrand, George Sarah J, Jackson Christopher L, Rogakos Vassilis, Beau Fabrice, Yiotakis Athanasios, Newby Andrew C, Dive Vincent
Abstract excerpt
OBJECTIVE: Matrix metalloproteinase (MMP)-12 has been implicated in plaque progression and instability and is also amenable to selective inhibition. In this study, we investigated the influence of a greater than 10-fold selective synthetic MMP-12 inhibitor on plaque progression in the apolipoprotein E knockout mouse model of atherosclerosis. METHODS AND RESULTS: A phosphinic peptide (RXP470.1) that is a potent,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
